An increase in RV expression has been documented in FTD–ALS postmortem tissue (24–26) suggesting that the RV silencing machinery might be disrupted potentially through TDP-43 dysfunction (27–29). The gene discussed is TARDBP; the disease is frontotemporal dementia.